logo

For the Inventor, By the Inventor

New York, NY, United States of America

Hidesaburo Hanafusa

This inventor holds 4 USPTO granted patents. Top assignee: The Rockefeller University. Active years: 1995-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hidesaburo Hanafusa. Retrieved from https://idiyas.com/inventor/hidesaburo-hanafusa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 82(Granted Patents)


Company Filing History:

goldMedal4 out of 751 
 
The Rockefeller University
 patents

Years Active: 1995-1999

Loading Chart...
4 patents (USPTO):Explore Patents
1. 5888763 - Peptides specific for the first Crk-SH3 domain (1999-03-30),
2. 5854045 - Transmembrane tyrosine phosphatase and methods of use thereof (1998-12-29),
3. 5693488 - Transmembrane tyrosine phosphatase, nucleic acids encoding the same, and (1997-12-02),
4. 5478724 - Lentivirus-specific nucleotide probes and methods of use (1995-12-26),

Title: Hidesaburo Hanafusa: Innovator in Cellular Regulation

Introduction

Hidesaburo Hanafusa is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cellular processes through his innovative patents. With a total of 4 patents, Hanafusa's work focuses on the regulation and control of cellular mechanisms.

Latest Patents

Hanafusa's latest patents include groundbreaking inventions. One of his notable patents is related to peptides specific for the first Crk-SH3 domain. This invention addresses the regulation of cellular processes by SH3-domain binding proteins and peptides. It provides a consensus sequence of a peptide that demonstrates high specificity and affinity for the first SH3 domain of cellular Crk. The molecular basis for this specificity is examined through crystallography.

Another significant patent is for transmembrane tyrosine phosphatase and methods of use thereof. This invention pertains to the regulation of cellular processes by transmembrane protein tyrosine phosphatases. It also includes ligands that can agonize or antagonize tyrosine phosphorylation mediated by such phosphatases. The invention introduces a novel transmembrane protein tyrosine phosphatase, PTP.lambda., along with nucleic acids encoding it, antibodies to PTP.lambda., and methods for identifying ligands to this protein.

Career Highlights

Hidesaburo Hanafusa is affiliated with The Rockefeller University, where he conducts his research and development. His work has significantly advanced the understanding of cellular processes and their regulation.

Collaborations

Hanafusa has collaborated with notable colleagues, including Kathy S Fang and Beatrice S Knudsen. These collaborations have further enriched his research and contributions to the field.

Conclusion

Hidesaburo Hanafusa is a distinguished inventor whose work in cellular regulation has led to multiple patents. His innovative approaches continue to influence the scientific community and enhance our understanding of cellular processes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…